GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a significant focus in therapeutic investigation, largely due to its impressive impact on managing conditions such as type 2 diabetes and obesity. New trials have revealed that in addition to glucose control, GLP-1 drugs offer benefits for cardiovascular well-bein… Read More